The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
Open accessAbstract
SummaryRecent evidence has linked long-term bisphosphonate use with insufficiency fractures of the femur in postmenopausal women. In this case–control study, we have identified a significant association between a unique fracture of the femoral shaft, a transverse fracture in an area of thickened cortices, and long-term bisphosphonate use. Further studies are warranted.IntroductionAlthough clinical trials confirm the anti-fracture efficacy of bisphosphonates over 3–5 years, the long-term effects of bisphosphonate use on bone metabolism are unknown. Femoral insufficiency factures in patients on prolonged treatment have been reported.MethodsWe performed a retrospective case–control study of postmenopausal women who presented with low-energy femoral fractures from 2000 to 2007. Forty-one subtrochanteric and femoral shaft fracture cases were identified and matched by age, race, and body mass index to one intertrochanteric and femoral neck fracture each.ResultsBisphosphonate use was observed in 15 of the 41 subtrochanteric/shaft cases, compared to nine of the 82 intertrochanteric/femoral neck controls (Mantel–Haenszel odds ratio (OR), 4.44 [95% confidence interval (CI) 1.77–11.35]; P = 0.002). A common X-ray pattern was identified in ten of the 15 subtrochanteric/shaft cases on a bisphosphonate. This X-ray pattern was highly associated with bisphosphonate use (OR, 15.33 [95% CI 3.06–76.90]; P < 0.001). Duration of bisphosphonate use was longer in subtrochanteric/shaft cases compared to both hip fracture controls groups (P = 0.001).ConclusionsWe found a significantly greater proportion of patients with subtrochanteric/shaft fractures to be on long-term bisphosphonates than intertrochanteric/femoral neck fractures. Bisphosphonate use was highly associated with a unique X-ray pattern. Further studies are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture
Lyles, K. W., Colón-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa074941 · Cited by 2,003
Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
Odvina, C. V., Zerwekh, J. E., Rao, D. S., Maalouf, N., Gottschalk, F. A., & Pak, C. Y. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0952 · Cited by 1,432
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 1×
“Furthermore, the suppression of bone turnover with bisphosphonate treatment in animals has been linked to the accumulation of microdamage in vivo [17–19, 40, 41].”
BackgroundGarnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Mashiba, T., Hirano, T., Turner, C. H., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.613 · Cited by 688
Boivin, G. Y., Chavassieux, P. M., Santora, A. C., Yates, J., & Meunier, P. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00376-8 · Cited by 574
Aging and matrix microdamage accumulation in human compact bone
Schaffler, M. B., Choi, K., & Milgrom, C. (1995) · Bone · doi:10.1016/8756-3282(95)00370-3 · Cited by 542
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs
Kavanagh, K. L., Guo, K., Dunford, J. E., Wu, X., Knapp, S., Ebetino, F. H., Rogers, M. J., Russell, R. G. G., & Oppermann, U. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601643103 · Cited by 536
Low-Energy Femoral Shaft Fractures Associated With Alendronate Use
Neviaser, A. S., Lane, J. M., Lenart, B. A., Edobor-Osula, F., & Lorich, D. G. (2008) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e318172841c · Cited by 526
Self-citationSubtrochanteric insufficiency fractures in patients on alendronate therapy: A CAUTION
Goh, S.-K., Yang, K. Y., Koh, J. S. B., Wong, M. K., Chua, S. Y., Chua, D. T. C., & Howe, T. S. (2007) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.89b3.18146 · Cited by 513
Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
Lenart, B. A., Lorich, D. G., & Lane, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707493 · Cited by 498
Self-citationMashiba, T., Turner, C. H., Hirano, T., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2001) · Bone · doi:10.1016/s8756-3282(01)00414-8 · Cited by 484
Bisphosphonate-Induced Osteopetrosis
Whyte, M. P., Wenkert, D., Clements, K. L., McAlister, W. H., & Mumm, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023110 · Cited by 446
Kwek, E. B. K., Goh, S. K., Koh, J. S. B., Png, M. A., & Howe, T. S. (2008) · Injury · doi:10.1016/j.injury.2007.08.036 · Cited by 445
Does microdamage accumulation affect the mechanical properties of bone?
Burr, D. B., Turner, C. H., Naick, P., Forwood, M. R., Ambrosius, W., Sayeed Hasan, M., & Pidaparti, R. (1998) · Journal of Biomechanics · doi:10.1016/s0021-9290(98)00016-5 · Cited by 417
Targeted and nontargeted remodeling
Burr, D. B. (2002) · Bone · doi:10.1016/s8756-3282(01)00619-6 · Cited by 414
Roschger, P., Rinnerthaler, S., Yates, J., Rodan, G. A., Fratzl, P., & Klaushofer, K. (2001) · Bone · doi:10.1016/s8756-3282(01)00485-9 · Cited by 384
Effects of differences in mineralization on the mechanical properties of bone
Currey, J. D. (1984) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1984.0042 · Cited by 352
Severely Suppressed Bone Turnover and Atypical Skeletal Fragility
Visekruna, M., Wilson, D., & McKiernan, F. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2803 · Cited by 270
Allen, M. R., Iwata, K., Phipps, R., & Burr, D. B. (2006) · Bone · doi:10.1016/j.bone.2006.04.028 · Cited by 253
Chavassieux, P., Seeman, E., & Delmas, P. D. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0029 · Cited by 219
Eriksen, E. F., Melsen, F., Sod, E., Barton, I., & Chines, A. (2002) · Bone · doi:10.1016/s8756-3282(02)00869-4 · Cited by 211
Changes in Bone Remodeling Rate Influence the Degree of Mineralization of Bone
Boivin, G., & Meunier, P. J. (2002) · Connective Tissue Research · doi:10.1080/03008200290000934 · Cited by 176
Li, J., Mashiba, T., & Burr, D. B. (2001) · Calcified Tissue International · doi:10.1007/s002230010036 · Cited by 176
Effects of damage morphology on cortical bone fragility
Diab, T., & Vashishth, D. (2005) · Bone · doi:10.1016/j.bone.2005.03.014 · Cited by 169
In vivo trabecular microcracks in human vertebral bone
Wenzel, T. E., Schaffler, M. B., & Fyhrie, D. P. (1996) · Bone · doi:10.1016/8756-3282(96)88871-5 · Cited by 164
Allen, M. R., Gineyts, É., Leeming, D. J., Burr, D. B., & Delmas, P. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0533-7 · Cited by 160
Population Based Epidemiologic and Morphologic Study of Femoral Shaft Fractures
Salminen, S. T., ki, H. K. P., Avikainen, V., & B�stman, O. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200003000-00026 · Cited by 150
The effect of the microscopic and nanoscale structure on bone fragility
Ruppel, M. E., Miller, L. M., & Burr, D. B. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0579-1 · Cited by 149
Stock, J. L., Bell, N. H., Chesnut, C. H., Ensrud, K. E., Genant, H. K., Harris, S. T., McClung, M. R., Singer, F. R., Yood, R. A., Pryor-Tillotson, S., et al. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00130-7 · Cited by 148
Failure of mineralized collagen fibrils: Modeling the role of collagen cross-linking
Siegmund, T. H., Allen, M. R., & Burr, D. B. (2008) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2008.02.017 · Cited by 141
Komatsubara, S., Mori, S., Mashiba, T., Li, J., Nonaka, K., Kaji, Y., Akiyama, T., Miyamoto, K., Cao, Y., Kawanishi, J., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040126 · Cited by 133
National Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003
Stafford, R. S., Drieling, R. L., & Hersh, A. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1525 · Cited by 116
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
Rossini, M., Gatti, D., Zamberlan, N., Braga, V., Dorizzi, R. M., & Adámi, S. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091121 · Cited by 106
Degradation of bone structural properties by accumulation and coalescence of microcracks
Danova, N. A., Colopy, S. A., Radtke, C. L., Kalscheur, V. L., Markel, M. D., Vanderby, R., McCabe, R. P., Escarcega, A. J., & Muir, P. (2003) · Bone · doi:10.1016/s8756-3282(03)00155-8 · Cited by 96
Specific Features Associated with Femoral Shaft Fractures Caused by Low-Energy Trauma
Salminen, S. T., PIHLAJAMÄKI, H. K., Avikainen, V., Kyrö, A., & Böstman, O. M. (1997) · doi:10.1097/00005373-199707000-00027 · Cited by 75
Fracture risk and antiresorptive medication use in older women in the USA
Gehlbach, S. H., Avrunin, J. S., Puleo, E., & Spaeth, R. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0310-z · Cited by 43
Cited by
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Self-citationCamacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182
“AFF of the subtrochanteric region is another rare event that seems to be increased with long-term bisphosphonate therapy (>5 years duration) and is also rarely seen with the higher dosing frequencies used in advanced cancer treatment (317-320).”
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Self-citationBisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695
Metadata
- Authors
- Lenart, B. A., Neviaser, A. S., Lyman, S., Chang, C. C., Edobor-Osula, F., Steele, B., van der Meulen, M. C. H., Lorich, D. G., & Lane, J. M.
- Venue
- Osteoporosis International
- Published
- 2008-12-09
- Volume
- 20
- Issue
- 8
- Pages
- 1353-1362
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2094638050
- Cited by
- 384
- References
- 41
- FWCI
- 36.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.